PharmaCielo Expands Product Portfolio With Bulk Cannabis Product Offerings – Benzinga

Medical cannabis company PharmaCielo (TSXV: PCLO) (OTCQX: PCLOF) announced Monday a significant expansion to its product portfolio of medical cannabis extracts and formulations. 

The Canadian-Colombian company now offers a comprehensive array of bulk products. The products contain diverse cannabinoids combinations; the line includes broad spectrum oils, CBD distillates, THC distillates, water soluble CBD, full spectrum oil tinctures, THC:CBD formulations, and CBD distillate tinctures.

PharmaCielo CEO David Attard said in a statement that “the announcement and availability of this new line of highly sought-after cannabis extracts is the accumulation of a multiyear investment we have made in our labs as well as in processing and extraction capabilities with new infrastructure that is coming online these days to enable the production of multiple extracts.

“This extended portfolio of new products such as Water Soluble CBD and Broad Spectrum for example, and increased production capacity give us the flexibility to produce and ship bulk products according to customers’ specifications on a very short timeframe and leverage opportunities with large players in the wellness-oriented beverage and topical product market segments.”

PharmaCielo confirmed it is taking orders for initial shipments of the new products.

© 2020 Benzinga does not provide investment advice. All rights reserved.